These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 34216669)

  • 21. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
    Xu T; Li S; Li AJ; Zhao J; Sakamuru S; Huang W; Xia M; Huang R
    J Chem Inf Model; 2023 Apr; 63(8):2321-2330. PubMed ID: 37011147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Usanmaz H; Taş Ö; Ekinci D; Uba AI; Atmaca U
    Future Med Chem; 2024; 16(11):1075-1085. PubMed ID: 38916565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
    Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
    Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
    Abdullaha M; Nuthakki VK; Bharate SB
    Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship investigation of tertiary amine derivatives of cinnamic acid as acetylcholinesterase and butyrylcholinesterase inhibitors: compared with that of phenylpropionic acid, sorbic acid and hexanoic acid.
    Gao X; Tang J; Liu H; Liu L; Kang L; Chen W
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):519-524. PubMed ID: 29447012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies.
    Iqbal J; al-Rashida M; Babar A; Hameed A; Khan MS; Munawar MA; Khan AF
    Med Chem; 2015; 11(5):489-96. PubMed ID: 25537128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies.
    Kia Y; Osman H; Kumar RS; Basiri A; Murugaiyah V
    Bioorg Med Chem; 2014 Feb; 22(4):1318-28. PubMed ID: 24461561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
    Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and cholinesterase inhibition of cativic acid derivatives.
    Alza NP; Richmond V; Baier CJ; Freire E; Baggio R; Murray AP
    Bioorg Med Chem; 2014 Aug; 22(15):3838-49. PubMed ID: 25017625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
    Atay MS; Sari S; Bodur E
    Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
    Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
    Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening.
    Gambardella MD; Wang Y; Pang J
    Molecules; 2024 May; 29(10):. PubMed ID: 38792196
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Nguyen HD; Kim MS
    J Biomol Struct Dyn; 2024 Sep; 42(14):7128-7149. PubMed ID: 37477246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase inhibitory activities of some flavonoids from the root bark of
    Cuong NM; Khanh PN; Nhung LTH; Ha NX; Huong TT; Bauerova K; Kim YH; Tung DD; Thuy TT; Anh NTH
    J Biomol Struct Dyn; 2024 Jun; 42(9):4888-4901. PubMed ID: 37325850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.